Literature DB >> 34185153

IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease.

Mara Cananzi1, Elizabeth Wohler2, Antonio Marzollo3,4, Nara Lygia de Macena Sobreira2, Helen C Su5, Anthony L Guerrerio6, Davide Colavito7, Jing You2, Huie Jing5, Silvia Bresolin3,4, Paola Gaio8, Renan Martin2, Claudia Mescoli9, Sangeeta Bade5, Jennifer E Posey10, Maurizio Dalle Carbonare7, Wesley Tung5, Shalini N Jhangiani11, Luca Bosa8, Yu Zhang5, Joselito Sobreira Filho12, Maria Gabelli3, Richard Kellermayer13, Howard A Kader14, Maria Oliva-Hemker15, Giorgio Perilongo8, James R Lupski10,11,16,17, Alessandra Biffi3, David Valle2, Alberta Leon7.   

Abstract

Genetic defects of innate immunity impairing intestinal bacterial sensing are linked to the development of Inflammatory Bowel Disease (IBD). Although much evidence supports a role of the intestinal virome in gut homeostasis, most studies focus on intestinal viral composition rather than on host intestinal viral sensitivity. To demonstrate the association between the development of Very Early Onset IBD (VEOIBD) and variants in the IFIH1 gene which encodes MDA5, a key cytosolic sensor for viral nucleic acids. Whole exome sequencing (WES) was performed in two independent cohorts of children with VEOIBD enrolled in Italy (n = 18) and USA (n = 24). Luciferase reporter assays were employed to assess MDA5 activity. An enrichment analysis was performed on IFIH1 comparing 42 VEOIBD probands with 1527 unrelated individuals without gastrointestinal or immunological issues. We identified rare, likely loss-of-function (LoF), IFIH1 variants in eight patients with VEOIBD from a combined cohort of 42 children. One subject, carrying a homozygous truncating variant resulting in complete LoF, experienced neonatal-onset, pan-gastrointestinal, IBD-like enteropathy plus multiple infectious episodes. The remaining seven subjects, affected by VEOIBD without immunodeficiency, were carriers of one LoF variant in IFIH1. Among these, two patients also carried a second hypomorphic variant, with partial function apparent when MDA5 was weakly stimulated. Furthermore, IFIH1 variants were significantly enriched in children with VEOIBD as compared to controls (p = 0.007). Complete and partial MDA5 deficiency is associated with VEOIBD with variable penetrance and expressivity, suggesting a role for impaired intestinal viral sensing in IBD pathogenesis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34185153      PMCID: PMC8423350          DOI: 10.1007/s00439-021-02300-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  59 in total

1.  RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium.

Authors:  Alexis H Broquet; Yoshihiro Hirata; Christopher S McAllister; Martin F Kagnoff
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Authors:  Samira Asgari; Luregn J Schlapbach; Stéphanie Anchisi; Christian Hammer; Istvan Bartha; Thomas Junier; Geneviève Mottet-Osman; Klara M Posfay-Barbe; David Longchamp; Martin Stocker; Samuel Cordey; Laurent Kaiser; Thomas Riedel; Tony Kenna; Deborah Long; Andreas Schibler; Amalio Telenti; Caroline Tapparel; Paul J McLaren; Dominique Garcin; Jacques Fellay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles.

Authors:  Zeynep Coban-Akdemir; Janson J White; Xiaofei Song; Shalini N Jhangiani; Jawid M Fatih; Tomasz Gambin; Yavuz Bayram; Ivan K Chinn; Ender Karaca; Jaya Punetha; Cecilia Poli; Eric Boerwinkle; Chad A Shaw; Jordan S Orange; Richard A Gibbs; Tuuli Lappalainen; James R Lupski; Claudia M B Carvalho
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

4.  Robust and powerful tests for rare variants using Fisher's method to combine evidence of association from two or more complementary tests.

Authors:  Andriy Derkach; Jerry F Lawless; Lei Sun
Journal:  Genet Epidemiol       Date:  2012-10-02       Impact factor: 2.135

5.  IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function.

Authors:  Achille Broggi; Yunhao Tan; Francesca Granucci; Ivan Zanoni
Journal:  Nat Immunol       Date:  2017-08-28       Impact factor: 25.606

6.  Rig-I-/- mice develop colitis associated with downregulation of G alpha i2.

Authors:  Yi Wang; Hong-Xin Zhang; Yue-Ping Sun; Zi-Xing Liu; Xue-Song Liu; Long Wang; Shun-Yuan Lu; Hui Kong; Qiao-Ling Liu; Xi-Hua Li; Zhen-Yu Lu; Sai-Juan Chen; Zhu Chen; Shi-San Bao; Wei Dai; Zhu-Gang Wang
Journal:  Cell Res       Date:  2007-10       Impact factor: 25.617

7.  RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.

Authors:  Christoph Coch; Jan Phillip Stümpel; Vanessa Lilien-Waldau; Dirk Wohlleber; Beate M Kümmerer; Isabelle Bekeredjian-Ding; Georg Kochs; Natalio Garbi; Stephan Herberhold; Christine Schuberth-Wagner; Janos Ludwig; Winfried Barchet; Martin Schlee; Achim Hoerauf; Friedrich Bootz; Peter Staeheli; Gunther Hartmann; Evelyn Hartmann
Journal:  Mol Ther       Date:  2017-07-08       Impact factor: 11.454

8.  Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.

Authors:  Michael J Ciancanelli; Sarah X L Huang; Priya Luthra; Hannah Garner; Yuval Itan; Stefano Volpi; Fabien G Lafaille; Céline Trouillet; Mirco Schmolke; Randy A Albrecht; Elisabeth Israelsson; Hye Kyung Lim; Melina Casadio; Tamar Hermesh; Lazaro Lorenzo; Lawrence W Leung; Vincent Pedergnana; Bertrand Boisson; Satoshi Okada; Capucine Picard; Benedicte Ringuier; Françoise Troussier; Damien Chaussabel; Laurent Abel; Isabelle Pellier; Luigi D Notarangelo; Adolfo García-Sastre; Christopher F Basler; Frédéric Geissmann; Shen-Ying Zhang; Hans-Willem Snoeck; Jean-Laurent Casanova
Journal:  Science       Date:  2015-03-26       Impact factor: 47.728

9.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

10.  Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities.

Authors:  Matthew N Bainbridge; Min Wang; Yuanqing Wu; Irene Newsham; Donna M Muzny; John L Jefferies; Thomas J Albert; Daniel L Burgess; Richard A Gibbs
Journal:  Genome Biol       Date:  2011-07-25       Impact factor: 13.583

View more
  3 in total

Review 1.  Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.

Authors:  Antonio Marzollo; Francesca Conti; Andrea Finocchi; Silvia Bresolin; Linda Rossini; Beatrice Rivalta; Lucia Leonardi; Caterina Tretti; Francesca Tosato; Maria Chiriaco; Giorgiana Madalina Ursu; Cristina Tea Natalucci; Maddalena Martella; Alessandro Borghesi; Cecilia Mancini; Andrea Ciolfi; Gigliola di Matteo; Marco Tartaglia; Caterina Cancrini; Andrea Dotta; Alessandra Biffi
Journal:  J Clin Immunol       Date:  2021-10-31       Impact factor: 8.317

2.  Effects of Lysophosphatidylcholine on Jejuna Morphology and Its Potential Mechanism.

Authors:  Xiaofeng Li; Abdel-Moneim Eid Abdel-Moneim; Noura M Mesalam; Bing Yang
Journal:  Front Vet Sci       Date:  2022-06-20

3.  Impact of surgical resection of butterfly glioblastoma on survival: a meta-analysis based on comparative studies.

Authors:  Rafał Chojak; Marta Koźba-Gosztyła; Katarzyna Słychan; Daniel Gajos; Marek Kotas; Michał Tyliszczak; Bogdan Czapiga
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.